Cg Oncology Inc [CGON] stock is trading at $41.79, up 0.65%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The CGON shares have gain 4.11% over the last week, with a monthly amount glided 1.02%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Cg Oncology Inc [NASDAQ: CGON] stock has seen the most recent analyst activity on December 11, 2025, when Wedbush initiated its Outperform rating and assigned the stock a price target of $70. On October 08, 2025, Guggenheim initiated with a Buy rating and assigned a price target of $90 on the stock. Piper Sandler started tracking the stock assigning an Overweight rating and suggested a price target of $55 on August 19, 2025. JP Morgan started tracking with an Overweight rating for this stock on May 02, 2025, and assigned it a price target of $41. In a note dated April 16, 2025, Scotiabank initiated an Sector Perform rating and provided a target price of $23 on this stock.
Cg Oncology Inc [CGON] stock has fluctuated between $14.80 and $46.01 over the past year. Currently, Wall Street analysts expect the stock to reach $69.5 within the next 12 months. Cg Oncology Inc [NASDAQ: CGON] shares were valued at $41.79 at the most recent close of the market. An investor can expect a potential return of 66.31% based on the average CGON price forecast.
Analyzing the CGON fundamentals
Cg Oncology Inc [NASDAQ:CGON] reported sales of 2.17M for the trailing twelve months, which represents a growth of 3774.42%. Gross Profit Margin for this corporation currently stands at 0.2% with Operating Profit Margin at -82.85%, Pretax Profit Margin comes in at -49.53%, and Net Profit Margin reading is -49.53%. To continue investigating profitability, this company’s Return on Assets is posted at -0.15, Equity is -0.15 and Total Capital is -0.26. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 41.03 points at the first support level, and at 40.27 for the second support level. However, for the 1st resistance point, the stock is sitting at 42.33, and for the 2nd resistance point, it is at 42.86.
Ratios To Look Out For
For context, Cg Oncology Inc’s Current Ratio is 22.79. As well, the Quick Ratio is 22.74, while the Cash Ratio is 1.48. Considering the valuation of this stock, the price to sales ratio is 1553.47, the price to book ratio is 4.76.
Transactions by insiders
Recent insider trading involved POST LEONARD E, Director, that happened on Nov 17 ’25 when 1000.0 shares were sold. Director, POST LEONARD E completed a deal on Oct 13 ’25 to sell 1000.0 shares. Meanwhile, Director Mulay James sold 5903.0 shares on Oct 09 ’25.
